Close Menu

NEW YORK – Heat Biologics, a Durham, North Carolina developer of therapeutic and prophylactic vaccines, said on Monday that it is collaborating with the University of Miami to develop a point-of-care diagnostic test for COVID-19.

The test is expected to require a pharyngeal throat swab to deliver diagnostic results on a paper strip in under 30 minutes. A spokesperson for Heat Biologics said in an email that the assay will use isothermal amplification technology to detect viral nucleic acids.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
13
Sponsored by
Beckman Coulter Life Sciences

Mitigation of the SARS-CoV-2 pandemic will continue to require innovative solutions. This webinar will outline how Fry Laboratories rapidly redeployed a next-generation sequencing (NGS) pipeline originally created for the detection and identification of bacterial, eukaryotic, and fungal infections in response to SARS-CoV-2.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.